SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-051633
Filing Date
2018-08-13
Accepted
2018-08-13 21:41:20
Documents
1
Period of Report
2018-08-13

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3616
  Complete submission text file 0001104659-18-051633.txt   4947
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Gibbs Craig S (Reporting) CIK: 0001614856 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38630 | Film No.: 181014050